Abstract：It is of great significance to promote the supply side reform, the focus of the current state reform, in order to guide the management of pediatric drugs and improve the safety and accessibility of children's medication. This paper studies the current situation and existing problems of children's medication in China, and analyzes the reasons for the poor accessibility and safety of children. From the perspective of supply side reform to study the safety and accessibility of children's treatment path, including the development of research and development path, policy support path, early warning mechanism path, model innovation path to ensure the safe and accessible medication for children to protect children′s effective supply for reference.
汤少梁 朱亚 冯莉钧 马蓉. 基于供给侧改革的我国儿童用药安全性与可及性优化路径研究[J]. 中国医药导报, 2017, 14(35): 125-129.
TANG Shaoliang ZHU Ya FENG Lijun MA Rong. The optimization path of safety and accessibility of pediatric drugs in China based on the supply side reform research. 中国医药导报, 2017, 14(35): 125-129.
2017, Vol. 14 
京公网安备 11010502046598号